EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.1.1.27 | L-lactate dehydrogenase |
pancreatic cancer cell |
- |
740255 |
1.1.1.40 | malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) |
pancreatic cancer cell |
- |
761332 |
1.11.1.12 | phospholipid-hydroperoxide glutathione peroxidase |
pancreatic cancer cell |
- |
673931 |
1.13.11.34 | arachidonate 5-lipoxygenase |
pancreatic cancer cell |
- |
711633 |
1.13.11.34 | arachidonate 5-lipoxygenase |
pancreatic cancer cell |
high enzyme expression level |
686278 |
1.14.14.18 | heme oxygenase (biliverdin-producing) |
pancreatic cancer cell |
- |
728211 |
1.14.17.3 | peptidylglycine monooxygenase |
pancreatic cancer cell |
- |
438581 |
1.2.1.3 | aldehyde dehydrogenase (NAD+) |
pancreatic cancer cell |
- |
689316 |
1.3.1.1 | dihydropyrimidine dehydrogenase (NAD+) |
pancreatic cancer cell |
- |
689367 |
1.3.1.6 | fumarate reductase (NADH) |
pancreatic cancer cell |
- |
710873 |
1.3.5.2 | dihydroorotate dehydrogenase (quinone) |
pancreatic cancer cell |
- |
763351 |
1.4.3.13 | protein-lysine 6-oxidase |
pancreatic cancer cell |
LOX gene expression is reduced in pancreatic cancer cells |
685949 |
1.6.5.2 | NAD(P)H dehydrogenase (quinone) |
pancreatic cancer cell |
- |
725775 |
1.6.5.2 | NAD(P)H dehydrogenase (quinone) |
pancreatic cancer cell |
overexpression |
724356 |
1.6.5.2 | NAD(P)H dehydrogenase (quinone) |
pancreatic cancer cell |
upregulation or overexpression of the enzyme in tumours |
694519 |
2.1.1.1 | nicotinamide N-methyltransferase |
pancreatic cancer cell |
- |
733636 |
2.3.1.50 | serine C-palmitoyltransferase |
pancreatic cancer cell |
strong overexpression of both SPT subunits |
659621 |
2.3.1.51 | 1-acylglycerol-3-phosphate O-acyltransferase |
pancreatic cancer cell |
- |
737122 |
2.3.2.13 | protein-glutamine gamma-glutamyltransferase |
pancreatic cancer cell |
- |
759712 |
2.3.2.2 | gamma-glutamyltransferase |
pancreatic cancer cell |
- |
487901 |
2.3.2.2 | gamma-glutamyltransferase |
pancreatic cancer cell |
HPC-Y1 |
487901 |
2.4.1.102 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase |
pancreatic cancer cell |
- |
735883, 736047 |
2.4.1.102 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase |
pancreatic cancer cell |
genetically engineered Kras-driven mouse pancreatic tumors |
-, 735883 |
2.4.1.150 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase |
pancreatic cancer cell |
over 95% of human pancreatic cancers are associated with Kras mutations |
758993 |
2.4.1.150 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase |
pancreatic cancer cell |
pancreas tumor tissue transcriptome analysis |
-, 758993 |
2.4.1.174 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase |
pancreatic cancer cell |
- |
759759 |
2.4.2.10 | orotate phosphoribosyltransferase |
pancreatic cancer cell |
- |
687155, 689294 |
2.4.2.10 | orotate phosphoribosyltransferase |
pancreatic cancer cell |
OPRT is involved in early events of pancreatic carcinogenesis |
676296 |
2.4.2.4 | thymidine phosphorylase |
pancreatic cancer cell |
- |
638468, 638469, 685924, 690098 |
2.4.2.4 | thymidine phosphorylase |
pancreatic cancer cell |
and adjacent nonmalignant pancreatic tissue |
673961 |
2.4.3.4 | beta-galactoside alpha-2,3-sialyltransferase |
pancreatic cancer cell |
- |
764905 |
2.5.1.59 | protein geranylgeranyltransferase type I |
pancreatic cancer cell |
- |
739426 |
2.5.1.60 | protein geranylgeranyltransferase type II |
pancreatic cancer cell |
- |
759873 |
2.6.1.1 | aspartate transaminase |
pancreatic cancer cell |
- |
758821 |
2.7.1.105 | 6-phosphofructo-2-kinase |
pancreatic cancer cell |
- |
737973, 739045, 761915 |
2.7.1.127 | inositol-trisphosphate 3-kinase |
pancreatic cancer cell |
- |
760540 |
2.7.1.154 | phosphatidylinositol-4-phosphate 3-kinase |
pancreatic cancer cell |
- |
761670 |
2.7.1.40 | pyruvate kinase |
pancreatic cancer cell |
- |
673438 |
2.7.1.74 | deoxycytidine kinase |
pancreatic cancer cell |
- |
703020, 706027, 723345 |
2.7.1.91 | sphingosine kinase |
pancreatic cancer cell |
- |
671356 |
2.7.10.1 | receptor protein-tyrosine kinase |
pancreatic cancer cell |
- |
661551, 672895, 690303 |
2.7.10.2 | non-specific protein-tyrosine kinase |
pancreatic cancer cell |
isoform c-Src and Notch-1 co-localize in tissues of pancreatic cancer patients |
723552 |
2.7.11.30 | receptor protein serine/threonine kinase |
pancreatic cancer cell |
- |
665640 |
2.7.12.2 | mitogen-activated protein kinase kinase |
pancreatic cancer cell |
- |
666517 |
2.7.12.2 | mitogen-activated protein kinase kinase |
pancreatic cancer cell |
weak expression |
677913 |
2.7.7.49 | RNA-directed DNA polymerase |
pancreatic cancer cell |
- |
692248 |
2.8.2.29 | [heparan sulfate]-glucosamine 3-sulfotransferase 2 |
pancreatic cancer cell |
- |
662996 |
3.4.19.12 | ubiquitinyl hydrolase 1 |
pancreatic cancer cell |
present in cancerous cells originating from tissues that do not normally express UCH-L1, including pancreatic cancer, colorectal cancer and invasive breast cancer |
752715 |
3.4.21.117 | stratum corneum chymotryptic enzyme |
pancreatic cancer cell |
- |
683785, 696964 |
3.4.21.117 | stratum corneum chymotryptic enzyme |
pancreatic cancer cell |
kallikrein 7 is overexpressed in pancreatic adenocarcinomas as well as other human cancers |
683126 |
3.4.21.117 | stratum corneum chymotryptic enzyme |
pancreatic cancer cell |
PCR expression profile of serine proteases from both healthy and malignant pancreatic tissues |
683325 |
3.4.21.26 | prolyl oligopeptidase |
pancreatic cancer cell |
- |
732142 |
3.4.21.4 | trypsin |
pancreatic cancer cell |
- |
696328 |
3.4.21.B41 | kallikrein 10 |
pancreatic cancer cell |
significantly upregulated |
670979 |
3.4.22.1 | cathepsin B |
pancreatic cancer cell |
from pancreatic ductal adenocarcinoma tissue |
697083 |
3.4.22.1 | cathepsin B |
pancreatic cancer cell |
from subcutaneous heteroplastic pancreatic carcinoma, quantitative cathepsin B expression analysis and modelling |
708137 |
3.4.22.61 | caspase-8 |
pancreatic cancer cell |
- |
697381 |
3.4.23.34 | cathepsin E |
pancreatic cancer cell |
- |
677830 |
3.4.24.23 | matrilysin |
pancreatic cancer cell |
exclusive detection of active enzyme in conditioned medium of dissociated cells, detection of proenzyme only in conditioned medium of non-dissociated cells. Enzyme protein is greatly reduced by treatment with the epidermal growth factor receptor inhibitor AG1478 and the mitogen activated protein kinase kinase inhibitor U0126 |
669633 |
3.4.24.B28 | ADAM15 |
pancreatic cancer cell |
- |
734701 |
3.4.24.B5 | matrix metalloproteinase-15 |
pancreatic cancer cell |
MMP-15 expression is significantly lower in tumor tissue compared with normal tissue |
668274 |
3.4.24.B7 | matrix metalloproteinase-26 |
pancreatic cancer cell |
- |
710794 |
3.4.24.B9 | ADAM9 endopeptidase |
pancreatic cancer cell |
- |
677587 |
3.4.25.1 | proteasome endopeptidase complex |
pancreatic cancer cell |
- |
711844 |
3.5.3.6 | arginine deiminase |
pancreatic cancer cell |
- |
692659 |
4.1.1.17 | ornithine decarboxylase |
pancreatic cancer cell |
- |
677508, 682982 |
4.1.1.28 | aromatic-L-amino-acid decarboxylase |
pancreatic cancer cell |
- |
681181 |
4.2.1.11 | phosphopyruvate hydratase |
pancreatic cancer cell |
ENOA complexes with annexin A2, cytokeratin 8 and tissue-type plasminogen activator in raft membrane fractions of pancreatic cancer cells |
714970 |
4.2.99.18 | DNA-(apurinic or apyrimidinic site) lyase |
pancreatic cancer cell |
- |
694162 |
5.6.2.2 | DNA topoisomerase (ATP-hydrolysing) |
pancreatic cancer cell |
- |
693540 |
6.3.5.4 | asparagine synthase (glutamine-hydrolysing) |
pancreatic cancer cell |
- |
672914 |